基于剪切波弹性成像的列线图预测乳腺癌21基因复发评分以辅助化疗决策
本研究回顾性纳入381例乳腺癌患者,利用剪切波弹性成像(SWE)弹性指数联合临床病理特征构建列线图,预测Oncotype DX复发评分(RS≥16和RS≥26)。结果显示基于SWE的列线图对RS≥26的预测AUC可达0.86(弹性比值),对RS≥16的AUC为0.74。结论认为SWE列线图可用于辅助系统性治疗决策。
要点
- SWE弹性指数(均值、最大值、比值)均与RS≥16和RS≥26独立相关。
- 预测RS≥26时,弹性比值列线图AUC最高(0.86),优于均值(0.81)和最大值(0.82)。
- 预测RS≥16时,均值与最大值列线图AUC均为0.74。
局限性
- 回顾性研究设计。
- 样本量有限(共381例,验证集95例)。
- 单中心研究(原文未明确多中心)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To develop and validate nomograms based on shear-wave elastography (SWE) combined with clinicopathologic features for predicting Oncotype DX recurrence score (RS) for use with adjuvant systemic therapy guidelines.
METHODS: In a retrospective study, patients with breast cancer who underwent definitive surgery of the breast between August 2011 and December 2019 were eligible for this study. Those with surgery between August 2011 and March 2019 were assigned to a development set and the rest were assigned to an independent validation set. Clinicopathologic features and SWE elasticity indices were assessed with logistic regression to develop nomograms for predicting RS ≥ 16 and ≥ 26. Analysis of the area under the receiver operating characteristic curve (AUROC) was used to assess the performance of the nomograms.
RESULTS: Of a total 381 women (mean age, 51 ± 9 years), 286 (mean age, 51 ± 9 years) were in the development set and 95 (mean age, 51 ± 9 years) in the validation set. All SWE elasticity indices were independently associated with each RS cutoff (odds ratio, 1.006-1.039 for RS ≥ 16; odds ratio, 1.008-1.076 for RS ≥ 26). Nomograms based on SWE combined with clinicopathologic features were developed and validated for RS ≥ 16 (mean elasticity [AUROC, 0.74; 95% CI: 0.68, 0.80] and maximum elasticity [AUROC, 0.74; 95% CI: 0.69, 0.80]) and for RS ≥ 26 (mean elasticity [AUROC, 0.81; 95% CI: 0.73, 0.89], maximum elasticity [AUROC, 0.82; 95% CI: 0.74, 0.89], and elasticity ratio [AUROC, 0.86; 95% CI: 0.80, 0.93]).
CONCLUSION: Nomograms based on SWE can predict Oncotype DX RS for use in adjuvant systemic therapy decisions.
引用
- Youk, Son, Jeong, et al. Shear-wave elastography-based nomograms predicting 21-gene recurrence score for adjuvant chemotherapy decisions in patients with breast cancer. Eur J Radiol. 2022. PMID: 36476677. doi:10.1016/j.ejrad.2022.110638
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。